Results 61 to 70 of about 1,146 (191)

An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient

Haematologica, 2007
An asymptomatic, 29-year-old woman was referred to our hospital before surgery because in the basic study of hemostasis she showed a prolonged thrombin time (TT) and a normal reptilase time (RT). She had not received any anticoagulants so, to account for
D. Llobet, M. Borrell, L. Vila, C. Vallvé, R. Felices, J. Fontcuberta   +5 more
doaj   +1 more source

Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing

Life, 2021
Diagnosis of rare bleeding disorders is challenging and there are several differential diagnostics issues. Next-generation sequencing (NGS) is a useful tool to overcome these problems.
Réka Gindele, Adrienne Kerényi, Judit Kállai, György Pfliegler, Ágota Schlammadinger, István Szegedi, Tamás Major, Zsuzsanna Szabó, Zsuzsa Bagoly, Csongor Kiss, János Kappelmayer, Zsuzsanna Bereczky   +11 more
doaj   +1 more source

Facts and Misfacts on D‐Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET)

American Journal of Hematology, Volume 101, Issue 1, Page 97-109, January 2026.
ABSTRACT D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start
Armando Tripodi, Walter Ageno, Luca Barcella, Antonio Coppola, Marcello Di Nisio, Massimo Franchini, Monia Marchetti, Rossella Marcucci, Marco Marietta, Pasquale Pignatelli, Domenico Prisco, Valerio De Stefano   +11 more
wiley   +1 more source

Fibrinogen dysfunction and fibrinolysis state in patients with hepatitis B-related cirrhosis

Hematology
Objective To assess the fibrinogen function in patients with hepatitis B-related cirrhosis and explore the relationship between dysfibrinogenemia and bleeding and thrombotic events.Methods Medical records and laboratory data of the patients with ...
Yu Liu, Yan Zhuang, Guanqun Xu, Xuefeng Wang, Lanyi Lin, Qiulan Ding   +5 more
doaj   +1 more source

Fibrinogen deficiency in a dog - a case report

BMC Veterinary Research, 2017
Background Among coagulation disorders, primary fibrinogen deficiency is very rare in dogs. It is divided into hypofibrinogenemia, afibrinogenemia and dysfibrinogenemia. Afibrinogenemia has been described in three dogs.
Franck Jolivet, Armelle Diquélou, Catherine Trumel, Simon Privat, Olivier Dossin   +4 more
doaj   +1 more source

Rare Coagulation Factor Deficiencies: Multicenter Experience With 188 Cases

Çocuk Dergisi, 2023
Objective: Rare factor deficiencies are a group of autosomal recessive bleeding disorders (with the exception of dysfibrinogenemia), which are characterized by the deficiency or dysfunction of one or more coagulation factors (F)I, FII, FV, FV+FVIII, FVII,
Veysel Gök, Esra Pekpak Şahinoğlu, Hüseyin Tokgöz, Fatma Türkan Mutlu, Can Acıpayam, Kamuran Karaman, Defne Ay Tuncel, Ayşe Ceyda Ören, Ayşe Şimşek, Bilal Arslan, Hatice Beyza Ünal, Alper Özcan, Ebru Yılmaz, Sinan Akbayram, Musa Karakükcü, Ahmet Fayik Öner, Ümran Çalışkan, Türkan Patıroğlu, Ekrem Ünal   +18 more
doaj   +1 more source

The Effect of Hepatitis B Infection on Levels of Fibrinogen, Protein C, and Protein S in Pregnant Women

Journal of Pregnancy, Volume 2026, Issue 1, 2026.
Background Viral hepatitis has been associated with profound alterations in the coagulation system as well as liver biomarkers. Meanwhile, during pregnancy, the coagulation system also undergoes significant changes with an increase in the majority of the clotting factors and a decrease in natural anticoagulants.
Abiba Alhassan Khalifah, Stephen Twumasi, Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Francis Agyei Amponsah, Joseph Frimpong, David Amoah Afrifah, Ernest Appiagyei, Albert Ntim Boadu, Daniel Nii Martey Antonio, Enoch Odame Anto, Nidhi Chaudhary   +11 more
wiley   +1 more source

Fibrinogen petoskey: Identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A [PDF]

, 1981
A new congenital dysfibrinogenemia, designated fibrinogen Petoskey, which was traced through four generations of a Michigan family, was found to exhibit an abnormally slow rate of release of fibrino-peptide A upon treatment with thrombin and batroxobin ...
Penner, John A., Higgins, Deborah L., Shafer, Jules A.   +2 more
core   +1 more source

DYSFIBRINOGENEMIA IN BURNED CHILDREN [PDF]

Pediatric Research, 1989
Severely burned children often show a dysfunction of microcirculation, due to overproduction of O2 radicals and to the activation of blood coagulation. We studied the effect of H2O2 on fibrinogen collected from burned children. Controls were healthy adult donors. Fibrinogen was purified through precipitation with PEG and saltin-out procedure.
Domenico Del Principe, Adriana Menichelli, Massimo Giordani, Carlo M Colucci, Claudio Colistra, Stefano Di Giulio   +5 more
openaire   +1 more source

Dysfibrinogenemia and hypofibrinogenemia - Spectrum of pathogenic variants in Slovak patients

Biomedical Papers
Introduction. Congenital hypofibrinogenemia (CH) and congenital dysfibrinogenemia (CD) are rare coagulation disorders caused by quantitative or qualitative defects in the fibrinogen gene.
Dominika Jaraskova, Jan Chandoga, Angelika Batorova, Tatiana Prigancova, Miriama Juhosova, Pavol Durina, Alzbeta Vavrova, Silvia Dallemule, Robert Petrovic, Anna Kyselova, Denisa Jankovicova, Daniel Bohmer   +11 more
doaj   +1 more source